摘要
血糖变异性又称血糖波动,是独立于糖化血红蛋白(hemoglobin A1c,HbA_(1c))、空腹血糖(fasting plasma glucose,FPG)、餐后血糖(postprandial plasma glucose,PPG)衡量血糖控制状况的另一维度,可以更全面地反映血糖的变化情况。越来越多的证据表明,血糖变异性与多种糖尿病不良结局相关。临床医生应该重新审视血糖变异性在血糖管理中的作用,通过科学、规范地评价以及合理、有效地管理来降低血糖波动的幅度,改善血糖变异性。
The blood glucose variability, also known as blood glucose fluctuation, is an index of glucose control which is independent of glycosylated hemoglobin（hemoglobin A1c, HbA_（1c））, fasting blood glucose（FPG）, postprandial blood glucose（PPG）. It can reflect the fluctuation of blood glucose in more comprehensive perspectives. More and more evidences suggested that blood glucose variability was closely related to multiple adverse outcomes of patients with diabetes. Clinicians should reexamine the status of blood glucose variability in blood glucose management. Under systematic normative evaluation and then rational effective management, it is expected that the amplitude of blood glucose fluctuation can be reduced and the blood glucose variability can be improved.
出处
《药品评价》
CAS
2017年第21期7-9,21,共4页
Drug Evaluation
关键词
糖尿病
血糖波动
血糖变异性
循证医学
Diabetes
Blood Glucose Fluctuation
Blood Glucose Variability
Evidence-based Medical Evidence
